Table 3: Percentages of the RA patient cohort using prednisolone, DMARDs and bDMARDs.

Medication information
Medication Number of RA patients (%)
Prednisolone 37 (43.5%)
DMARD Total: 71 (82.6%)
Methotrexate: 58 (67.4%)
Plaquenil: 28 (32.9%)
Sulfasalazine: 18 (21.2%)
Leflunomide: 12 (12.8%)
bDMARD 32 (37.6%)